$OPCH
Option Care Health, Inc.

2022 Q1 Form 10-Q Financial Statement

#000101473922000024 Filed on April 28, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $915.8M $927.2M $759.2M
YoY Change 20.62% 15.22% 7.63%
Cost Of Revenue $714.8M $715.0M $593.8M
YoY Change 20.39% 15.14% 8.47%
Gross Profit $200.9M $212.2M $165.5M
YoY Change 21.43% 15.47% 4.71%
Gross Profit Margin 21.94% 22.89% 21.79%
Selling, General & Admin $134.0M $136.8M $120.0M
YoY Change 11.6% 4.57% -7.15%
% of Gross Profit 66.67% 64.46% 72.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $14.72M $15.98M $16.34M
YoY Change -9.9% -10.2% -18.72%
% of Gross Profit 7.33% 7.53% 9.87%
Operating Expenses $148.7M $151.4M $136.4M
YoY Change 9.03% 8.63% -8.7%
Operating Profit $52.25M $60.77M $29.09M
YoY Change 79.57% 37.05% 236.42%
Interest Expense $12.25M -$12.82M $19.48M
YoY Change -37.14% -43.51% -30.64%
% of Operating Profit 23.44% -21.1% 66.96%
Other Income/Expense, Net $2.000K -$10.77M -$12.40M
YoY Change -100.02% -53.18% -155112.5%
Pretax Income $41.27M $46.97M -$1.583M
YoY Change -2706.95% 155.26% -91.62%
Income Tax $11.00M -$28.50M $1.300M
% Of Pretax Income 26.66% -60.68%
Net Earnings $30.28M $75.47M -$2.861M
YoY Change -1158.2% 323.05% -85.63%
Net Earnings / Revenue 3.31% 8.14% -0.38%
Basic Earnings Per Share $0.17 -$0.02
Diluted Earnings Per Share $0.17 $415.4K -$0.02
COMMON SHARES
Basic Shares Outstanding 180.0M shares 179.9M shares 179.8M shares
Diluted Shares Outstanding 181.7M shares 179.8M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $145.6M $119.4M $109.4M
YoY Change 33.09% 20.26% 41.71%
Cash & Equivalents $145.6M $119.4M $109.4M
Short-Term Investments
Other Short-Term Assets $76.64M $69.50M $57.90M
YoY Change 32.37% -1.84% 21.38%
Inventory $217.2M $183.1M $173.6M
Prepaid Expenses
Receivables $366.3M $338.2M $323.9M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $805.7M $710.3M $664.7M
YoY Change 21.21% 8.1% 10.55%
LONG-TERM ASSETS
Property, Plant & Equipment $109.1M $111.5M $116.3M
YoY Change -6.23% -7.94% -7.53%
Goodwill $1.479B $1.478B $1.429B
YoY Change 3.49% 3.43% 0.05%
Intangibles
YoY Change
Long-Term Investments $21.40M $20.10M $18.20M
YoY Change 17.58% 18.24% 7.06%
Other Assets $37.75M $23.73M $21.87M
YoY Change 72.58% 13.99% 0.68%
Total Long-Term Assets $2.073B $2.081B $1.976B
YoY Change 4.9% 4.53% -1.77%
TOTAL ASSETS
Total Short-Term Assets $805.7M $710.3M $664.7M
Total Long-Term Assets $2.073B $2.081B $1.976B
Total Assets $2.878B $2.791B $2.640B
YoY Change 9.01% 5.42% 1.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $356.1M $279.2M $290.9M
YoY Change 22.4% -1.3% 9.5%
Accrued Expenses $146.0M $174.4M $117.5M
YoY Change 24.27% 33.47% 16.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $6.000M $6.000M $11.78M
YoY Change -49.04% -35.14% 27.3%
Total Short-Term Liabilities $508.1M $459.7M $420.2M
YoY Change 20.94% 5.91% 10.85%
LONG-TERM LIABILITIES
Long-Term Debt $1.059B $1.060B $1.121B
YoY Change -5.5% -4.95% -12.16%
Other Long-Term Liabilities $13.45M $20.95M $8.974M
YoY Change 49.82% 147.17% -69.79%
Total Long-Term Liabilities $1.148B $1.155B $1.202B
YoY Change -4.48% -3.54% -11.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $508.1M $459.7M $420.2M
Total Long-Term Liabilities $1.148B $1.155B $1.202B
Total Liabilities $1.657B $1.615B $1.622B
YoY Change 2.1% -1.02% -6.87%
SHAREHOLDERS EQUITY
Retained Earnings $70.14M $39.87M -$102.9M
YoY Change -168.17% -139.85% -8.02%
Common Stock $1.143B $1.139B $1.130B
YoY Change 1.14% 0.85% 12.08%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.403M $2.403M $2.403M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares 383.7K shares 383.7K shares 383.7K shares
Shareholders Equity $1.222B $1.176B $1.018B
YoY Change
Total Liabilities & Shareholders Equity $2.878B $2.791B $2.640B
YoY Change 9.01% 5.42% 1.07%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income $30.28M $75.47M -$2.861M
YoY Change -1158.2% 323.05% -85.63%
Depreciation, Depletion And Amortization $14.72M $15.98M $16.34M
YoY Change -9.9% -10.2% -18.72%
Cash From Operating Activities $32.68M $65.31M $18.38M
YoY Change 77.81% 154.12% -0.12%
INVESTING ACTIVITIES
Capital Expenditures $5.359M -$13.89M $3.123M
YoY Change 71.6% -0.8% -41.66%
Acquisitions
YoY Change
Other Investing Activities -$67.06M
YoY Change
Cash From Investing Activities -$5.359M -$80.95M -$3.123M
YoY Change 71.6% 478.18% -41.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$1.145M -65.80M -$5.160M
YoY Change -77.81% 25.57% 80.29%
NET CHANGE
Cash From Operating Activities $32.68M 65.31M $18.38M
Cash From Investing Activities -$5.359M -80.95M -$3.123M
Cash From Financing Activities -$1.145M -65.80M -$5.160M
Net Change In Cash $26.18M -81.43M $10.10M
YoY Change 159.26% 100.08% -0.89%
FREE CASH FLOW
Cash From Operating Activities $32.68M $65.31M $18.38M
Capital Expenditures $5.359M -$13.89M $3.123M
Free Cash Flow $27.32M $79.20M $15.26M
YoY Change 79.08% 99.49% 16.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001014739
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei City Area Code
CityAreaCode
312
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-11993
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
OPTION CARE HEALTH, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
05-0489664
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3000 Lakeside Dr.
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300N,
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bannockburn,
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60015
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
940-2443
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
CY2022Q1 dei Trading Symbol
TradingSymbol
OPCH
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
180052037 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
145600000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119423000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
366285000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
338242000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
217184000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
183095000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
76643000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
69496000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
805712000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
710256000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
109066000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111535000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
74662000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
74777000 USD
CY2022Q1 bios Finite Lived Intangible Assets Net Excluding Customer Lists
FiniteLivedIntangibleAssetsNetExcludingCustomerLists
20669000 USD
CY2021Q4 bios Finite Lived Intangible Assets Net Excluding Customer Lists
FiniteLivedIntangibleAssetsNetExcludingCustomerLists
21433000 USD
CY2022Q1 bios Finite Lived Customer Lists Net
FiniteLivedCustomerListsNet
337882000 USD
CY2021Q4 bios Finite Lived Customer Lists Net
FiniteLivedCustomerListsNet
344587000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
1478500000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
1477564000 USD
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14037000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
27033000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37748000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23733000 USD
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
2072564000 USD
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2080662000 USD
CY2022Q1 us-gaap Assets
Assets
2878276000 USD
CY2021Q4 us-gaap Assets
Assets
2790918000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
356118000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
279246000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
42046000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
83503000 USD
CY2022Q1 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
85286000 USD
CY2021Q4 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
71857000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
18689000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19089000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
508139000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
459695000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1059449000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1059900000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
75479000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74492000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13445000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20945000 USD
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1148373000 USD
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1155337000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
1656512000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
1615032000 USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12500000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12500000 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
180429758 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
180046036 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
180309637 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
179925915 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
18000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
18000 USD
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
383722 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
383722 shares
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2403000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2403000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1143388000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1138855000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
70142000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39867000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10619000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-451000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1221764000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1175886000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2878276000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2790918000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
915784000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
759237000 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
714848000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
593764000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
200936000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
165473000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
133969000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
120040000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14722000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16339000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
148691000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
136379000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
52245000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
29094000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
12246000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
19481000 USD
CY2022Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1267000 USD
CY2021Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1205000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12401000 USD
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-10977000 USD
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-30677000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
41268000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1583000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10993000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1278000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
30275000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2861000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
3763000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
11070000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
4081000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11070000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3810000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4081000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
41345000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1220000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179961000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179808000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181681000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
179808000 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
30275000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2861000 USD
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
15979000 USD
CY2021Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
17716000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3884000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
12996000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
634000 USD
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12403000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1049000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1253000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1267000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1205000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4178000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1205000 USD
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
291000 USD
CY2021Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
96000 USD
CY2022Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
28766000 USD
CY2021Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-4450000 USD
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
34089000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15021000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6241000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-12946000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
76872000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
8026000 USD
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-41481000 USD
CY2021Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-18208000 USD
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
13520000 USD
CY2021Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-2357000 USD
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
4246000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
5160000 USD
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
10273000 USD
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-653000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32681000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18380000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5359000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3123000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5359000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3123000 USD
CY2022Q1 bios Proceeds From Payments For Stock Options Exercised Restricted Stock Vested And Tax Withholding
ProceedsFromPaymentsForStockOptionsExercisedRestrictedStockVestedAndTaxWithholding
355000 USD
CY2021Q1 bios Proceeds From Payments For Stock Options Exercised Restricted Stock Vested And Tax Withholding
ProceedsFromPaymentsForStockOptionsExercisedRestrictedStockVestedAndTaxWithholding
-69000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
355200000 USD
CY2022Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
1500000 USD
CY2021Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
2944000 USD
CY2022Q1 us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
0 USD
CY2021Q1 us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
352009000 USD
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2880000 USD
CY2022Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 USD
CY2021Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
2458000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1145000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5160000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
26177000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10097000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
119423000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99265000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145600000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109362000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
5104000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
21502000 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
61000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
111000 USD
CY2022Q1 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
6242000 USD
CY2021Q1 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
6768000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1015724000 USD
CY2021Q1 bios Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings
StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings
69000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1205000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2861000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4081000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1018080000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1175886000 USD
CY2022Q1 bios Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings
StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings
-355000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4178000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
30275000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11070000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1221764000 USD
CY2022Q1 bios Number Of Infusion Sites
NumberOfInfusionSites
57 suite
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q1 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
47600000 USD
CY2021Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
43000000 USD
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
21400000 USD
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
20100000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1300000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1200000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1300000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
915784000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
759237000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1300000 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.266
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.807
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.266
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.807
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13200000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
30275000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2861000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179961000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179808000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
30275000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2861000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179961000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
179808000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1720000 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
181681000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
179808000 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
7300000 USD
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
7500000 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y10M24D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0509
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
19872000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
20992000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
15416000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12682000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9697000 USD
CY2022Q1 bios Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
34371000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
113030000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
18862000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
94168000 USD
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3800000 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
235945000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
230357000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
126879000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
118822000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
109066000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111535000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
8445000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
8975000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
1477564000 USD
CY2022Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
936000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
1478500000 USD
CY2021Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
530955000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
530955000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
172404000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
164935000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
358551000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
366020000 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7500000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8700000 USD
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1098500000 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
9288000 USD
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
23763000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
1065449000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1059449000 USD
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1100000000 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
9605000 USD
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
24495000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
1065900000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6000000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1059900000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
4500000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
6000000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6000000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6000000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
6000000 USD
CY2022Q1 bios Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
1070000000 USD
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1098500000 USD
CY2022Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1065449000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
14833000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
4081000 USD
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
694000 USD
CY2021Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4150000 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
9101734 shares

Files In Submission

Name View Source Status
0001014739-22-000024-index-headers.html Edgar Link pending
0001014739-22-000024-index.html Edgar Link pending
0001014739-22-000024.txt Edgar Link pending
0001014739-22-000024-xbrl.zip Edgar Link pending
bios-20220331.htm Edgar Link pending
bios-20220331.xsd Edgar Link pending
bios-20220331_cal.xml Edgar Link unprocessable
bios-20220331_def.xml Edgar Link unprocessable
bios-20220331_g1.jpg Edgar Link pending
bios-20220331_htm.xml Edgar Link completed
bios-20220331_lab.xml Edgar Link unprocessable
bios-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
opch-ex311x20220331x10q.htm Edgar Link pending
opch-ex312x20220331x10q.htm Edgar Link pending
opch-ex321x20220331x10q.htm Edgar Link pending
opch-ex322x20220331x10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending